Rossari Biotech registers PAT of Rs 35 crore in Q1 FY27
Mumbai, July 20 -- On the expenditure front, COGS added up to Rs 490.8 crore (up 32.2% YoY), employee benefits expenses amounted to Rs 44.1 crore (up 17.6% YoY) and other expenses aggregated to Rs 81.7 crore (up 21.9% YoY) in the June 2026 quarter.
While EBITDA improved by 19% YoY to Rs 80.6 crore, EBITDA margin contracted by 90 basis points YoY to 11.6% in Q1 FY27.
Profit before tax in Q1 FY27 stood at Rs 47.7 crore, up by 3.5% from Rs 46.1 crore in Q1 FY26.
Edward Menezes, promoter & executive chairman, and Sunil Chari, promoter & managing director, said: "We commenced FY27 on a strong note, delivering robust consolidated revenue growth of 28% YoY.
The performance was driven by healthy momentum in the domestic business and the conti...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.